Sinsin Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	89,961	82,376	94,664	84,651	97,850	138,658
Market Cap Growth	7.82%	-12.98%	11.83%	-13.49%	-29.43%	34.02%
Enterprise Value	132,473	122,361	135,899	130,024	145,574	183,301
Last Close Price	5930.00	5354.84	6085.51	5387.79	6171.41	8745.23
PE Ratio	13.85	16.85	20.23	19.18	-	382.34
PS Ratio	0.82	0.77	0.92	0.92	1.32	2.07
PB Ratio	1.27	1.26	1.53	1.42	1.79	2.47
P/TBV Ratio	1.27	1.26	1.53	1.43	1.80	2.49
P/FCF Ratio	35.60	18.56	-	18.59	-	-
P/OCF Ratio	17.12	13.86	24.09	15.50	4220.66	74.34
EV/Sales Ratio	1.20	1.15	1.33	1.41	1.97	2.73
EV/EBITDA Ratio	10.32	10.97	13.67	14.16	62.51	-
EV/EBIT Ratio	15.40	17.76	22.64	23.96	-	-
EV/FCF Ratio	52.42	27.57	-	28.56	-	-
Debt / Equity Ratio	0.63	0.70	0.72	0.73	0.84	0.81
Debt / EBITDA Ratio	3.47	4.09	4.48	4.73	19.85	-
Debt / FCF Ratio	17.63	10.27	-	9.55	-	-
Net Debt / Equity Ratio	0.60	0.69	0.71	0.69	0.83	0.76
Net Debt / EBITDA Ratio	3.34	4.04	4.44	4.49	19.51	-26.91
Net Debt / FCF Ratio	16.94	10.15	-40.84	9.06	-17.09	-4.22
Asset Turnover	0.83	0.84	0.84	0.78	0.64	0.54
Inventory Turnover	4.07	4.34	4.60	4.98	4.60	3.85
Quick Ratio	0.62	0.56	0.59	0.71	0.76	0.77
Current Ratio	0.95	0.87	0.91	1.06	1.08	1.15
Return on Equity (ROE)	9.54%	7.54%	7.64%	7.62%	-2.61%	0.36%
Return on Assets (ROA)	4.05%	3.39%	3.06%	2.88%	-0.72%	-2.11%
Return on Invested Capital (ROIC)	7.07%	5.95%	5.80%	5.40%	-1.35%	-4.02%
Return on Capital Employed (ROCE)	11.70%	9.80%	8.30%	6.90%	-1.70%	-5.00%
Earnings Yield	7.23%	5.93%	4.94%	5.21%	-1.51%	0.26%
FCF Yield	2.81%	5.39%	-1.14%	5.38%	-2.72%	-7.29%
Dividend Yield	1.01%	1.12%	-	-	-	-
Payout Ratio	14.00%	18.62%	16.21%	-	-	117.13%
Buyback Yield / Dilution	-0.13%	-	-	-	-	-
Total Shareholder Return	0.88%	1.12%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.